96 related articles for article (PubMed ID: 8687346)
1. Acute morbidity of radiation therapy for prostate carcinoma.
Franklin CI
Australas Radiol; 1996 May; 40(2):140-5. PubMed ID: 8687346
[TBL] [Abstract][Full Text] [Related]
2. Bladder and intestinal injuries following radiation therapy of carcinoma of the uterine cervix.
Johnsson JE
Acta Radiol Ther Phys Biol; 1976 Dec; 15(6):541-9. PubMed ID: 829591
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Effects of Prostate Radiation Therapy on Occludin Expression and Ultrasonography Characteristics of the Bladder.
Baradaran-Ghahfarokhi M; Amouheidari A; Shahbazi-Gahrouei D; Baradaran-Ghahfarokhi HR; Tanderup K; Dörr W; Shokrani P
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):963-971. PubMed ID: 28807533
[TBL] [Abstract][Full Text] [Related]
4. Low-grade toxicity after conformal radiation therapy for prostate cancer--impact of bladder volume.
Pinkawa M; Fischedick K; Asadpour B; Gagel B; Piroth MD; Eble MJ
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):835-41. PubMed ID: 16289911
[TBL] [Abstract][Full Text] [Related]
5. Late effects of radiation therapy for prostate carcinoma: the patient's perspective of bladder, bowel and sexual morbidity.
Franklin CI; Parker CA; Morton KM
Australas Radiol; 1998 Feb; 42(1):58-65. PubMed ID: 9509607
[TBL] [Abstract][Full Text] [Related]
6. Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial.
Bruner DW; Hunt D; Michalski JM; Bosch WR; Galvin JM; Amin M; Xiao C; Bahary JP; Patel M; Chafe S; Rodrigues G; Lau H; Duclos M; Baikadi M; Deshmukh S; Sandler HM
Cancer; 2015 Jul; 121(14):2422-30. PubMed ID: 25847819
[TBL] [Abstract][Full Text] [Related]
7. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
[TBL] [Abstract][Full Text] [Related]
8. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective.
Crook J; Esche B; Futter N
Urology; 1996 Mar; 47(3):387-94. PubMed ID: 8633407
[TBL] [Abstract][Full Text] [Related]
9. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
[TBL] [Abstract][Full Text] [Related]
10. Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II.
Michalski JM; Winter K; Purdy JA; Wilder RB; Perez CA; Roach M; Parliament MB; Pollack A; Markoe AM; Harms W; Sandler HM; Cox JD
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):192-8. PubMed ID: 12694838
[TBL] [Abstract][Full Text] [Related]
11. Assessment of external beam radiation technology for dose escalation and normal tissue protection in the treatment of prostate cancer.
D'Ambrosio DJ; Pollack A; Harris EE; Price RA; Verhey LJ; Roach M; Demanes DJ; Steinberg ML; Potters L; Wallner PE; Konski A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):671-7. PubMed ID: 18262085
[No Abstract] [Full Text] [Related]
12. Patient-reported intestinal toxicity from whole pelvis intensity-modulated radiotherapy: First quantification of bowel dose-volume effects.
Sini C; Noris Chiorda B; Gabriele P; Sanguineti G; Morlino S; Badenchini F; Cante D; Carillo V; Gaetano M; Giandini T; Landoni V; Maggio A; Perna L; Petrucci E; Sacco V; Valdagni R; Rancati T; Fiorino C; Cozzarini C
Radiother Oncol; 2017 Aug; 124(2):296-301. PubMed ID: 28739383
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy of inoperable localized prostate carcinoma: an assessment of tumor response and complications.
Green N; Melbye RW; George FW; Morrow J
J Urol; 1974 May; 111(5):662-4. PubMed ID: 4207372
[No Abstract] [Full Text] [Related]
14. Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.
McCammon R; Rusthoven KE; Kavanagh B; Newell S; Newman F; Raben D
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):413-20. PubMed ID: 19362783
[TBL] [Abstract][Full Text] [Related]
15. Is "pelvic radiation disease" always the cause of bowel symptoms following prostate cancer intensity-modulated radiotherapy?
Min M; Chua B; Guttner Y; Abraham N; Aherne NJ; Hoffmann M; McKay MJ; Shakespeare TP
Radiother Oncol; 2014 Feb; 110(2):278-83. PubMed ID: 24412017
[TBL] [Abstract][Full Text] [Related]
16. Bladder and rectal toxicity of BeamCath application in radiotherapy of prostate cancer.
Hanssen S; Norum J
Anticancer Res; 2008; 28(5B):2865-8. PubMed ID: 19031926
[TBL] [Abstract][Full Text] [Related]
17. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study.
Koper PC; Stroom JC; van Putten WL; Korevaar GA; Heijmen BJ; Wijnmaalen A; Jansen PP; Hanssens PE; Griep C; Krol AD; Samson MJ; Levendag PC
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):727-34. PubMed ID: 10098427
[TBL] [Abstract][Full Text] [Related]
18. Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population.
Hanlon AL; Watkins Bruner D; Peter R; Hanks GE
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):51-9. PubMed ID: 11163497
[TBL] [Abstract][Full Text] [Related]
19. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial.
Koper PC; Jansen P; van Putten W; van Os M; Wijnmaalen AJ; Lebesque JV; Levendag PC
Radiother Oncol; 2004 Oct; 73(1):1-9. PubMed ID: 15465140
[TBL] [Abstract][Full Text] [Related]
20. [Prostate cancer: radiotherapy or operation?].
Aktuelle Urol; 2013 Mar; 44(2):103-4. PubMed ID: 23592289
[No Abstract] [Full Text] [Related]
[Next] [New Search]
